Inhibitory Effects of Chronic Ethanol Consumption on Cellular Immune Responses to Hepatitis C Virus Core Protein Are Reversed by Genetic Immunizations Augmented with Cytokine-Expressing Plasmids

Journal of Immunology

Volumn 159, Issue 10, 1997, Pages 5107-5113

  Geissler, Michael ^a   Gesien, Annett ^a   Wands, Jack R ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CORE PROTEIN; CYTOKINE; DNA VACCINE; IMMUNOLOGICAL ADJUVANT; IMMUNOSUPPRESSIVE AGENT; NUCLEOCAPSID PROTEIN, HEPATITIS C VIRUS; VIRUS ANTIBODY;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; CD4+ T LYMPHOCYTE; CELL LINE; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; DIET; DRUG EFFECT; FEMALE; GENE VECTOR; GENETICS; HEPATITIS C VIRUS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MOUSE; PLASMID; SECRETION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CYTOKINES; DIET; ETHANOL; FEMALE; GENETIC VECTORS; HEPACIVIRUS; IMMUNITY, CELLULAR; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; PLASMIDS; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, DNA; VIRAL CORE PROTEINS;

EID: 0031573081     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Alter, M. J., H. S. Margolis, K. Krawczynski, F. N. Judson, A. Mares, W. J. Alexander, P. Y. Hu, J. K. Miller, M. A. Gerber, R. E. Sampliner, E. L. Meeks, and M. J. Beach. 1992. The natural history of community-acquired hepatitis C in the United States: the sentinel counties chronic non-A, non-B hepatitis study team. N. Engl. J. Med. 327:1899.
2. Noda, K., H. Yoshihara, K. Suzuki, Y. Yamada, A. Kasahara, N. Hayashi, H. Fusamoto, and T. Kamada. 1996. Progression of type C chronic hepatitis to liver cirrhosis and hepatocellular carcinoma - its relationship to alcohol drinking and the age of transfusion. Alcohol Clin. Exp. Res. 20:95A.
3. Tsukuma, H., T. Hiyama, S. Tanaka, M. Nakao, T. Yabuuchi, T. Kitamura, K. Nakanishi, I. Fujimoto, A. Inoue, H. Yamazaki, and T. Kawashima, 1993. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N. Engl. J. Med. 328:1797.
4. Saito, I., T. Miyamura, A. Ohbayashi, H. Harada, T. Katayama, S. Kikuchi, Y. Watanabe, S. Koi, M. Onji, Y. Ohta, Q. L. Choo, M. Houghton, and G. Kuo. 1990. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA 87:6547.
5. Okino, S. T., and J. J. Whitlock. 1995. HCV-associated liver cancer without cirrhosis. Lancet 345:413.
6. Pares, A., J. M. Barrera, J. Caballeria, G. Ercilla, M. Bruguera, L. Caballeria, R. Castillo, and J. Rodes. 1990. Hepatitis C virus antibodies in chronic alcoholic patients: association with severity of liver injury. Hepatology 12:1295.
7. Caldwell, S. H., L. J. Jeffers, A. Ditomaso, A. Millar, R. M. Clark, A. Rabassa, K. R. Reddy, M. M. De, and E. R. Schiff. 1991. Antibody to hepatitis C is common among patients with alcoholic liver disease with and without risk factors. Am. J. Gastroenterol. 86:1219.
8. Mendenhall, C. L., L. Seeff, A. M. Diehl, S. J. Ghosn, S. W. French, P. S. Gartside, S. D. Rouster, B. Z. Buskell, C. J. Grossman, G. A. Roselle, R. E. Weesner, P. Garcia-Pont, S. J. Goldberg, T. W. Kiernan, C. H. Tamburro, R. Zetterman, A. Chedid, T. Chen, and L. Rabin. 1991. Antibodies to hepatitis B virus and hepatitis C virus in alcoholic hepatitis and cirrhosis: their prevalence and clinical relevance: the VA Cooperative Study Group. Hepatology 14:581.
9. Nishiguchi, S., T. Kuroki, T. Yabusako, S. Seki, K. Kobayashi, T. Monna, S. Otani, M. Sakurai, T. Shikata, and S. Yamamoto. 1991. Detection of hepatitis C virus antibodies and hepatitis C virus RNA in patients with alcoholic liver disease. Hepatology 14:985.
10. von Weizsacker, F., E. Maedi, N. V. Brown, T. Poynard, E. Galun, S. Labeit, J. C. Caput, T. Arima, H. Blum, and J. R. Wands. 1995. Hepatitis B and C virus infection in HBsAg-negative alcoholics without i.v. drug abuse or previous blood transfusions. Int. Hepatol. Commun. 4:80.
11. Zignego, A. L., M. Foschi, G. Laffi, M. Monti, G. Careccia, R. G. Romanelli, M. E. De Majo, R. Mazzanti, G. Buzzelli, V. G. La, and P. Gentilini. 1994. "Inapparent" hepatitis B virus infection and hepatitis C virus replication in alcoholic subjects with and without liver disease. Hepatology 19:577.
12. Diepolder, H. M., R. Zachoval, R. M. Hoffmann, E. A. Wierenga, T. Santantonio, M. C. Jung, D. Eichenlaub, and G. R. Pape. 1995. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346:1006.
13. Bertoletti, A., M. M. D'Elios, C. Boni, C. M. De Carli, A. L. Zignego, M. Durazzo, G. Missale, A. Penna, F. Fiaccadori, P. G. Del, and C. Ferrari. 1997. Different cytokine profiles of intrahepatic T cells in chronic hepatitis B and hepatitis C virus infections. Gastroenterology 112:193.
14. Ferrari, C., A. Valli, L. Galati, A. Penna, P. Scaccaglia, T. Giuberti, C. Schianchi, G. Missale, M. G. Marin, and F. Fiaccadori. 1994. T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections. Hepatology 19:286.
15. Missale, G., R. Bertoni, V. Lamonaca, A. Valli, M. Massari, C. Mori, M. G. Rumi, M. Houghton, F. Fiaccadori, and C. Ferrari. 1996. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J. Clin. Invest. 98:706.
16. Rehermann, B., K. M. Chang, J. McHutchinson, R. Kokka, M. Houghton, and F. V. Chisari. 1996. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. J. Clin. Invest. 98:1432.
17. Rehermann, B., K. M. Chang, J. McHutchinson, R. Kokka, M. Houghton, C. M. Rice, and F. V. Chisari. 1996. Differential cytotoxic T lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients. J. Virol. 70:7092.
18. Leroux, R. G., C. A. Esquivel, R. DeLeys, L. Stuyver, A. Elewaut, J. Philippe, I. Desombere, J. Paradijs, and G. Maertens. 1996. Lymphoproliferative responses to hepatitis C virus core, E1, E2, and NS3 in patients with chronic hepatitis C infection treated with interferon alpha. Hepatology 23:8.
19. Iwata, K., T. Wakita, A. Okumura, K. Yoshioka, M. Takayanagi, J. R. Wands, and S. Kakumu. 1995. Interferon gamma production by peripheral blood lymphocytes to hepatitis C virus core protein in chronic hepatitis C infection. Hepatology 22:1057.
20. Koziel, M. J., D. Dudley, N. Afdhal, Q. L. Choo, M. Houghton, R. Ralston, and B. D. Walker. 1993. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J. Virol. 67:7522.
21. Kita, H., T. Moriyama, T. Kaneko, I. Harase, M. Nomura, H. Miura, I. Nakamura, Y. Yazaki, and M. Imawari. 1993. HLA B44-restricted cytotoxic T lymphocytes recognizing an epitope on hepatitis C virus nucleocapsid protein. Hepatology 18:1039.
22. Cerny, A., J. G. McHutchison, C. Pasquinelli, M. E. Brown, M. A. Brothers, B. Grabscheid, P. Fowler, M. Houghton, and F. V. Chisari. 1995. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. J. Clin. Invest. 95:521.
23. Battegay, M., J. Fikes, B. A. Di, P. A. Wentworth, A. Sette, E. Celis, W. M. Ching, A. Grakoui, C. M. Rice, K. Kurokohchi, J. A. Berzofsky, J. H. Hoofnagle, S. M. Feinstone, and T. Akatsuka. 1995. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. J. Virol. 69:2462.
24. Shirai, M., H. Okada, M. Nishioka, T. Akatsuka, C. Wychowski, R. Houghten, C. D. Pendleton, S. M. Feinstone, and J. A. Berzofsky. 1994. An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans. J. Virol. 68:3334.
25. Wong, D., D. Dudley, N. Afdhal, C. Rice, M. Houghton, B. Walker, and M. Koziel. 1996. Liver derived cytotoxic T lymphocytes in non resolving hepatitis C infection. IX Triennial International Symposium on Viral Hepatitis and Liver Disease. (Abstr. D44).
26. Wolff, J. A., R. W. Malone, P. Williams, W. Chong, G. Acsadi, A. Jani, and P. L. Felgner. 1990. Direct gene transfer into mouse muscle in vivo. Science 247:1465.
27. Tang, D., M. DeVit, and S. A. Johnston. 1992. Genetic immunization is a simple method for eliciting an immune response. Nature 356:152.
28. Geissler, M., A. Gesien, K. Tokushige, and J. R. Wands. 1997. Enhancement of cellular and humoral immune responses to hepatitis C virus (HCV) core protein using DNA based vaccines augmented with cytokine expressing plasmids. J. Immunol. 158:1231.
29. Geissler, M., A. Gesien, and J. R. Wands. 1997. Cellular immune responses to HCV core protein are impaired by chronic ethanol exposure in vivo: an immunologic mechanism for induction of persistent viral infection. Proceedings of the 4th International Meeting on Hepatitis C Virus and Related Viruses. In press.
30. Tokushige, K., T. Wakita, C. Pachuk, D. Moradpour, D. Weiner, V. R. Zurawski Jr., and J. R. Wands. 1996. Expression and immune response to hepatitis C virus core DNA-based vaccine constructs. Hepatology 24:14.
31. Tokushige, K., D. Moradpour, T. Wakita, M. Geissler, N. Hayashi, and J. R. Wands. 1997. Comparison between cytomegalovirus promoter and elongation factor-1a promoter-driven constructs in the establishment of cell lines expressing hepatitis C virus core protein. J. Virol. Methods 64:73.
32. Mendenhall, C. L., C. J. Grossman, G. A. Roselle, S. Ghosn, P. S. Gartside, S. D. Rouster, P. V. Chalasani, G. Schmitt, K. Martin, and K. Lamping. 1990. Host response to mycobacterial infection in the alcoholic rat. Gastroenterology 99:1723.
33. Geissler, M., G. Wands, A. Gesien, S. de la Monte, D. Bellet, and J. Wands. 1997. Genetic immunization with the free human chorionic gonadotropin β subunit elicits cytotoxic T lymphocyte responses and protects against tumor formation in mice. Lab. Invest. 76:1.
34. Lagging, L. M., K. Meyer, D. Hoft, M. Houghton, R. B. Belshe, and R. Ray. 1995. Immune responses to plasmid DNA encoding the hepatitis C virus core protein. J. Virol. 69:5859.
35. + T lymphocytes. J. Immunol. 155:259.
36. Martins, L. P., L. L. Lau, M. S. Asano, and R. Ahmed. 1995. DNA vaccination against persistent viral infection. J. Virol. 69:2574.
37. Xiang, Z. Q., S. L. Spitalnik, J. Cheng, J. Erikson, B. Wojczyk, and H. C. Ertl. 1995. Immune responses to nucleic acid vaccines to rabies virus. Virology 209:569.
38. Yasutomi, Y., H. L. Robinson, S. Lu, F. Mustafa, C. Lekutis, J. Arthos, J. I. Mullins, G. Voss, K. Manson, M. Wyand, and N. L. Letvin. 1996. Simian immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeys. J. Virol. 70:678.
39. Yokoyama, M., J. Zhang, and J. L. Whitton. 1995. DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection. J. Virol. 69:2684.
40. Yankauckas, M. A., J. E. Morrow, S. E. Parker, A. Abai, G. H. Rhodes, V. J. Dwarki, and S. H. Gromkowski. 1993. Long-term anti-nucleoprotein cellular and humoral immunity is induced by intramuscular injection of plasmid DNA containing NP gene. DNA Cell Biol. 9:771.
41. Whalen, R. G., and H. L. Davis. 1995. DNA-mediated immunization and the energetic immune response to hepatitis B surface antigen. Clin. Immunol. Immunopathol. 75:1.
42. Jayasinghe, R., G. Gianutsos, and A. K. Hubbard. 1992. Ethanol-induced suppression of cell-mediated immunity in the mouse. Alcohol Clin. Exp. Res. 16:331.
43. + cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance. Proc. Natl. Acad. Sci. USA 90:948.
44. Clerici, M., F. T. Hakim, D. J. Venzon, S. Blatt, C. W. Hendrix, T. A. Wynn, and G. M. Shearer. 1993. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J. Clin. Invest. 91:759.
45. Cook, R. T., M. J. Garvey, B. M. Booth, J. A. Goeken, B. Stewart, and M. Noel. 1991. Activated CD-8 cells and HLA DR expression in alcoholics without overt liver disease. J. Clin. Immunol. 11:246.
46. Kato, S., I. Kurose, H. Higuchi, H. Ebinuma, H. Saito, S. Miura, and H. Ishii. 1996. Effect of chronic ethanol feeding on Kupffer cell-mediated antitumor cell activity. Alcohol Clin. Exp. Res. 20:46A.
47. Mikszta, J. A., C. Waltenbaugh, and B. S. Kim. 1995. Impaired antigen presentation by splenocytes of ethanol-consuming C57BL/6 mice. Alcohol 12:265.
48. Caux, C., D. C. Dezutter, D. Schmitt, and J. Banchereau. 1992. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 360:258.
49. Elliott, M. J., A. Strasser, and D. Metcalf. 1991. Selective up-regulation of macrophage function in granulocyte-macrophage colony-stimulating factor transgenic mice. J. Immunol. 147:2957.
50. Fischer, H. G., S. Frosch, K. Reske, and K. A. Reske. 1988. Granulocyte-macrophage colony-stimulating factor activates macrophages derived from bone marrow cultures to synthesis of MHC class II molecules and to augmented antigen presentation function. J. Immunol. 141:3882.
51. Fischer, H. G., B. Opel, K. Reske, and K. A. Reske. 1988. Granulocyte-macrophage colony-stimulating factor-cultured bone marrow-derived macrophages reveal accessory cell function and synthesis of MHC class II determinants in the absence of external stimuli. Eur. J. Immunol. 18:1151.
52. Morrissey, P. J., L. Bressler, L. S. Park, A. Alpert, and S. Gillis. 1987. Granulocyte-macrophage colony-stimulating factor augments ihe primary antibody response by enhancing the function of antigen-presenting cells. J. Immunol. 139:1113.
53. Malkovsky, M., B. Loveland, M. North, G. L. Asherson, L. Gao, P. Ward, and W. Fiers. 1987. Recombinant interleukin-2 directly augments the cytotoxicity of human monocytes. Nature 325:262.
54. Belosevic, M., D. S. Finbloom, M. S. Meltzer, and C. A. Nacy. 1990. IL-2: A cofactor for induction of activated macrophage resistance to infection. J. Immunol. 145:831.
55. Oppenheim, J. J., C. O. Zachariae, N. Mukaida, and K. Matsushima. 1991. Properties of ihe novel proinflammatory supergene "intercrine" cytokine family. Annu. Rev. Immunol. 9:617.